Mymetics CorpOver The Counter Market:MYMX
- LAST PRICE0.0010
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0010
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Mymetics Corp | 150.0 | 0.0x | --- |
Kaleido Biosciences Inc | 4.3K | 0.0x | --- |
Baudax Bio Inc | 40.0 | 0.0x | --- |
Quick-Med Technologies Inc | 40.0 | 0.0x | --- |
Affymax Inc | 30.0K | 0.0x | --- |
Statera Biopharma Inc | 7.1K | 0.0x | --- |
Company Information
Mymetics Corporation is a vaccine company. The Company is focused on developing vaccines for infectious diseases. The Company has over five vaccine candidates in its pipeline: human immunodeficiency virus type 1 (HIV-1)/acquired immune deficiency syndrome (AIDS), intra nasal Influenza, Malaria, Herpes Simplex Virus (HSV) and the Respiratory Syncitial Virus (RSV) vaccine. Its technology utilizes virosomes, lipid-based carriers containing functional fusion viral proteins and natural membrane proteins, in combination with rationally designed antigens. Its prophylactic HIV-1 vaccine candidate is constituted of virosomes linked to conserved antigens derived from the HIV-1 glycoprotein 41 (gp41) proteins from the clade B. The RSV vaccine consists of the reconstituted membrane of RSV containing the native viral proteins. The HSV vaccine candidate consists of the reconstituted membrane of HSV-1 or HSV-2. The intranasal influenza vaccine includes the reconstituted membrane of influenza virus.
Contact Information
- Headquarters
- Route De La Corniche 4EPALINGES, Switzerland 1066
- Phone
- ---
- Fax
- ---
Executives
- President, Chief Executive Officer, Chief Financial Officer
- Ronald Kempers
- Chief Scientific Officer
- Sylvain Fleury
- Director
- Ulrich Burkhard
- Independent Director
- Marcel Ruegg
- Independent Director
- Thomas Staehelin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $150.00 |
|---|---|
Revenue (TTM) | $556.2K |
Shares Outstanding | 151.9K |
Mymetics Corp does not pay a dividend. | |
Beta | 1.84 |
EPS | $-79.92 |
Book Value | $-448.39 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,703.96% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
